Alexium International Group Limited · ASX:AJX
Alexium International — H1 FY2023 Earnings Presentation
16 slides from Alexium International's earnings presentation, Feb 24, 2023
Slide 1: FY2023 Half Year Results
ALEXIUM INTERNATIONAL GROUP LIMITED FY2023 Half Year Results 24 February 2023 ABN 91 064 820 408 PRESENTED IN US DOLLARS
Slide 2: Disclaimer
Disclaimer To the maximum extent permitted by law, the information contained in this presentation is given without any liability whatsoever being accepted by Alexium International Group Limited (Alexium) or any of its related entities or their respective directors or officers, employees, advisors an
Slide 3: Company Overview
Company Overview “Alexium’s value to customers is technology enabling them to create a unique user experience that drives higher sales volumes at improved margins…” A performance materials company leveraging proprietary technical innovations to deliver thermal regulation, dehumidification and flam
Slide 4: Alexium Core Technologies
Alexium Core Technologies AlexiCool® PCM-based cooling products for textile & foam applications AlexiCool ® BioCool® BioCool® Proprietary bio-based cooling products for textile & foam applications Eclipsys™ Eclipsys™ Perpetual cooling technology for textile & foam-based products DelCool DelCool Dehu
Slide 5: FY23 & FY24 Market Development Priorities
FY23 & FY24 - Market development priorities Grow and diversify through four key enablers: grow and diversify bedding market revenue, commercialise Eclipsys™ for tactical gear, commercialise FR Nyco for military, and continued innovation. Core Focus Areas (70%) – Bedding market revenue: PCM, DelCool
Slide 6: Market Development – FY23 2H Priorities
Market development – FY23 2H Priorities Bedding Focus - Milestones: Core Focus: • Q3: Increased BioCool® sales to new customers in the US bedding market for mattress, pillow and bed topper applications Grow & Diversify Bedding Market Revenue • Q3: DelCool sales commence in pillow applications • Q4:
Slide 7: Bedding – Grow and diversify
Bedding – Grow and diversify WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY? IN 2H FY23 ALEXIUM • AlexiCool®/BioCool® brands are established premium • Continued revenue growth in textile • Revenue growth from new customers of the products (received an Innovation Award from Serta applications in mattress
Slide 8: Eclipsys for Tactical Gear
Eclipsys™ for Tactical Gear WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY? IN 2H FY23 ALEXIUM • Improvements to Eclipsys™ technology and • New trials commence in Q3 FY23 at • New revenue streams from new customers. manufacturing process led to new numerous customers. opportunities for product adoption.
Slide 9: FR NyCo for Military Uniforms
FR NyCo for military uniforms & WHERE WE ARE KEY NEXT STEPS VALUE TO TODAY? IN 2H FY23 ALEXIUM • Alexium has created a flame-resistant nylon • Deliver treated fabric for cut-and-sew of • New & large revenue streams + cotton fabric treatment utilising a uniforms for military field testing based on •
Slide 10: Half Year Financial Results
AY ALEXIUM Half Year Financial Results
Slide 11: Financial Snapshot
Financial Snapshot Signs of recovery in bedding market Revenue decreased 35.0% vs 1H FY22 but up 18.9% from H2 FY22 as bedding market continues its recovery Net cash outflows from operating activities decreased by $0.2m to ($1.2m) due to lower revenue Operating expenses remain flat compared to
Slide 12: Cash Flow Statement
Cash Flow Statement • Operating Activities outflows increased $0.2m with changes in: ($3.0m) – cash receipts $2.6m - reduced product purchases $0.2m – all other costs • Financing Activities increased $1.5m with changes in: $1.0m – proceeds from modification of convertible note $0.5m – timi
Slide 13: Profit & Loss Statement
Profit & Loss Statement • Revenue decreased as bedding market continues its recovery • Gross Profit down $0.8m with decreased gross margin and revenue • Operating expenses flat • Interest Expense up with the addition of Alterna line of credit • Loss on Debt Extinguishment ($0.6) related to the amend
Slide 14: Balance Sheet
Balance Sheet • Net Working Capital • Overall working capital increased by $0.1M versus comparative period. Trade receivables & trade payables were higher, and inventory decreased due to lower sales. • Non-Current Assets • Decrease of $0.1m with minimal additions to fixed and intangible assets. • Cu
Slide 15: Non-GAAP Financial Measure Reconciliation
Non-GAAP Financial Measure Reconciliation Reconciliation of Operating EBITDA (non-GAAP financial measure) to statutory Net Profit/(Loss) The consolidated financial statements of the Group are general purpose financial statements which have been prepared in accordance with the Australian Accounting S
Slide 16: @YALexium
@YALexium
Alexium International Group — H1 FY2023 Earnings Presentation on 6ix